Rockefeller Capital Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$74.1K Buy
2,302
+583
+34% +$21.6K ﹤0.01% 3042
2025
Q4
$72.4K Buy
1,719
+1,141
+197% +$46K ﹤0.01% 2886
2025
Q3
$19.8K Buy
+578
New +$16.6K ﹤0.01% 3361
2023
Q1
Sell
-67
Closed -$1K 3816
2022
Q4
$1K Sell
67
-341
-84% -$7.92K ﹤0.01% 3773
2022
Q3
$6K Sell
408
-331
-45% -$7.45K ﹤0.01% 3302
2022
Q2
$14K Buy
739
+511
+224% +$10.3K ﹤0.01% 2961
2022
Q1
$6K Sell
228
-217
-49% -$6.21K ﹤0.01% 3297
2021
Q4
$17K Buy
445
+121
+37% +$5.35K ﹤0.01% 2726
2021
Q3
$15K Sell
324
-97
-23% -$4.23K ﹤0.01% 2717
2021
Q2
$16K Hold
421
﹤0.01% 2590
2021
Q1
$22K Buy
421
+45
+12% +$2.59K ﹤0.01% 2244
2020
Q4
$18K Buy
376
+279
+288% +$12.9K ﹤0.01% 2059
2020
Q3
$3K Hold
97
﹤0.01% 2370
2020
Q2
$3K Hold
97
﹤0.01% 2267
2020
Q1
$2K Buy
+97
New +$2.44K ﹤0.01% 2216

Other funds holding VCYT

Rockefeller Capital Management's VCYT Position: Q1 2026 in Review

Rockefeller Capital Management increased its Veracyte (VCYT) stake by 34% in Q1 2026, buying an estimated $21.6K and bringing the position to 2,302 shares worth $74.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3042.

Rockefeller Capital Management first reported a position in VCYT in Q1 2020 and has held it in 15 quarters since. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Rockefeller Capital Management held 2,302 shares of Veracyte worth $74.1K as of Q1 2026.
  • Rockefeller Capital Management bought 583 Veracyte shares in Q1 2026, an estimated $21.6K.
  • Veracyte made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #3042 holding.
  • Rockefeller Capital Management first reported a position in Veracyte in Q1 2020 and has held it in 15 quarters since.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.